The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers

por Ngoi, Natalie YL, Tan, David SP
Publicado 2019

Exploiting replicative stress in gynecological cancers as a therapeutic strategy

por Ngoi, Natalie YL, Sundararajan, Vignesh, Tan, David SP
Publicado 2020

The redox-senescence axis and its therapeutic targeting

por Ngoi, Natalie YL., Liew, Angeline QX., Chong, Stephen J.F., Davids, Matthew S., Clement, Marie-Veronique, Pervaiz, Shazib
Publicado 2021

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

por Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun
Publicado 2021

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma

por Heong, Valerie, Tan, Tuan Z, Miwa, Maiko, Ye, Jieru, Lim, Diana, Herrington, C Simon, Iida, Yasushi, Yano, Mitsutake, Yasuda, Masanori, Ngoi, Natalie YL, Wong, SB Justin, Okamoto, Aikou, Gourley, Charlie, Hasegawa, Kosei, Tan, David SP, Huang, Ruby YJ
Publicado 2021

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

por Ngoi, Natalie YL, Heong, Valerie, Ow, Samuel, Chay, Wen Yee, Kim, Hee Seung, Choi, Chel Hun, Goss, Geraldine, Goh, Jeffrey C, Tai, Bee Choo, Lim, Diana GZ, Kaliaperumal, Nivashini, Au, Veonice B, Connolly, John E, Kim, Jae-Weon, Friedlander, Michael, Kim, Kidong, Tan, David SP
Publicado 2020